⌘K

Login Start Free

Home/Filings/4/0001437749-12-009901

4//SEC Filing

Shields Paul 4

Accession 0001437749-12-009901

CIK 0000352747other

View on SEC.gov Company Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:24 PM ET

Size

6.9 KB

Accession

0001437749-12-009901

Insider Transaction Report

Form 4

Period: 2012-09-27

UNIGENE LABORATORIES INCUGNE

Vice Pres. Mfg. Operations

Transactions

Award
Stock Option
2012-09-27+556,645→ 1,270,109 total
Exercise: $0.10From: 2013-09-27Exp: 2022-09-26→ Common Stock (556,645 underlying)
Award
Stock Option
2012-09-27+177,025→ 713,464 total
Exercise: $0.25Exp: 2022-09-26→ Common Stock (177,025 underlying)

Footnotes (1)

[F1]88,512 stock options will become exercisable on August 1, 2013 and 88,513 stock options will become exercisable on August 1, 2014

Documents

1 file

4
rdgdoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

UNIGENE LABORATORIES INC

CIK 0000352747

Entity typeother

Related Parties

1

filerCIK 0001319237

Filing Metadata

Form type: 4
Filed: Sep 30, 8:00 PM ET
Accepted: Oct 1, 4:24 PM ET
Size: 6.9 KB

View on SEC.gov